Emmaus Life Sciences Inc (QB) (EMMA)
USOTC
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease. Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.00226 | 17.7254901961 | 0.01275 | 0.01501 | 0.01275 | 6099 | 0.01397589 | CS |
4 | 0.00791 | 111.408450704 | 0.0071 | 0.01501 | 0.0071 | 20977 | 0.0102448 | CS |
12 | -0.01737 | -53.6442248301 | 0.03238 | 0.0499 | 0.0039 | 49698 | 0.01324111 | CS |
26 | 0.01391 | 1264.54545455 | 0.0011 | 0.0499 | 0.0001 | 63847 | 0.01212235 | CS |
52 | -0.108115 | -87.8091370558 | 0.123125 | 0.13215 | 0.0001 | 37665 | 0.02860647 | CS |
156 | -1.29499 | -98.8541984733 | 1.31 | 1.7 | 0.0001 | 29923 | 0.22584312 | CS |
260 | -1.23499 | -98.7992 | 1.25 | 4 | 0.0001 | 24784 | 0.65557077 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.